Molekulargenetische Diagnostik
Praxis Dr. Mato Nagel

Hämochromatose 1

Die Hämochromatose 1 ist eine autosomal rezessive Eisenspeicherkrankheit, die durch Mutationen im HFE-Gen hervorgerufen wird. Das BMP2_gen zeigt offensichtlich eine Modifizierende Wirkung bei der Ausbildung des Phänotyps.

Gliederung

Hämochromatose
Hämochromatose 1
BMP2
HFE
Hämochromatose 2a
Hämochromatose 2b
Hämochromatose 3
Hämochromatose 4
Hämochromatose 5

Referenzen:

1.

de Sousa M et. al. (1994) Iron overload in beta 2-microglobulin-deficient mice.

[^]
2.

Milet J et. al. (2007) Common variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathway modulate HFE hemochromatosis penetrance.

[^]
3.

Hentze MW et. al. (1986) Cloning, characterization, expression, and chromosomal localization of a human ferritin heavy-chain gene.

[^]
4.

Cragg SJ et. al. (1985) Genes for the 'H' subunit of human ferritin are present on a number of human chromosomes.

[^]
5.

Simon M et. al. (1977) Heredity of idiopathic haemochromatosis.

[^]
6.

Halliday JW et. al. (1977) Serum-ferritin in diagnosis of haemochromatosis. A study of 43 families.

[^]
7.

Cox TM et. al. (1978) Uptake of iron by duodenal biopsy specimens from patients with iron-deficiency anaemia and primary haemochromatosis.

[^]
8.

Sargent T et. al. (1979) Reduced chromium retention in patients with hemochromatosis, a possible basis of hemochromatotic diabetes.

[^]
9.

Feller ER et. al. (1977) Familial hemochromatosis. Physiologic studies in the precirrhotic stage of the disease.

[^]
10.

Beaumont C et. al. (1979) Serum ferritin as a possible marker of the hemochromatosis allele.

[^]
11.

Cartwright GE et. al. (1979) Hereditary hemochromatosis. Phenotypic expression of the disease.

[^]
12.

None (1979) Genetic linkage and hemosiderosis.

[^]
13.

Kravitz K et. al. (1979) Genetic linkage between hereditary hemochromatosis and HLA.

[^]
14.

Walsh CH et. al. (1978) Proliferative retinopathy in a patient with diabetes mellitus and idiopathic haemochromatosis.

[^]
15.

Lipinski M et. al. (1978) Idiopathic hemochromatosis: linkage with HLA.

[^]
16.

Kühnl P et. al. (1978) HLA antigens in patients with idiopathic hemochromatosis (IH).

[^]
17.

Cartwright GE et. al. (1978) Inheritance of hemochromatosis: linkage to HLA.

[^]
18.

Lamon JM et. al. (1979) Idiopathic hemochromatosis in a young female. A case study and review of the syndrome in young people.

[^]
19.

None (1979) Clinical conferences at The Johns Hopkins Hospital. Familial hemochromatosis.

[^]
20.

Simon M et. al. (1977) Heredity of idiopathic haemochromatosis: a study of 106 families.

[^]
21.

Edwards CQ et. al. (1977) Hereditary hemochromatosis. Diagnosis in siblings and children.

[^]
22.

Rowe JW et. al. (1977) Familial hemochromatosis: characteristics of the precirrhotic stage in a large kindred.

[^]
23.

Simon M et. al. (1977) Idiopathic hemochromatosis. Demonstration of recessive transmission and early detection by family HLA typing.

[^]
24.

Wands JR et. al. (1976) Normal serum ferritin concentrations in precirrhotic hemochromatosis.

[^]
25.

Simon M et. al. (1976) Association of HLA-A3 and HLA-B14 antigens with idiopathic haemochromatosis.

[^]
26.

Boretto J et. al. (1992) Anonymous markers located on chromosome 6 in the HLA-A class I region: allelic distribution in genetic haemochromatosis.

[^]
27.

Yaouanq J et. al. (1992) Familial screening for genetic haemochromatosis by means of DNA markers.

[^]
28.

Kaikov Y et. al. (1992) Primary hemochromatosis in children: report of three newly diagnosed cases and review of the pediatric literature.

[^]
29.

Rabinovitz M et. al. (1992) Association between heterozygous alpha 1-antitrypsin deficiency and genetic hemochromatosis.

[^]
30.

Milman N et. al. (1992) An HLA study in 74 Danish haemochromatosis patients and in 21 of their families.

[^]
31.

Zappone E et. al. (1991) Polymorphism in a ferritin H gene from chromosome 6p.

[^]
32.

None (1992) Intrafamilial variation in hereditary hemochromatosis.

[^]
33.

Milman N et. al. (1992) Transferrin subtypes in 51 Danish patients with hereditary haemochromatosis and in 847 normal subjects.

[^]
34.

Summers KM et. al. (1991) Fine mapping of a human chromosome 6 ferritin heavy chain pseudogene: relevance to haemochromatosis.

[^]
35.

Dokal I et. al. (1991) Detection of hereditary haemochromatosis in an HLA-identical pedigree showing discordance between HLA class I genes and the disease locus.

[^]
36.

Bullen JJ et. al. (1991) Hemochromatosis, iron and septicemia caused by Vibrio vulnificus.

[^]
37.

None (1991) Hereditary haemochromatosis in Denmark 1950-1985. Clinical, biochemical and histological features in 179 patients and 13 preclinical cases.

[^]
38.

Jouanolle AM et. al. (1990) HLA class I gene polymorphism in genetic hemochromatosis.

[^]
39.

Worwood M et. al. (1991) Hereditary haemochromatosis and blood donation.

[^]
40.

Lord DK et. al. (1990) Molecular analysis of the human MHC class I region in hereditary haemochromatosis. A study by pulsed-field gel electrophoresis.

[^]
41.

Dugast IJ et. al. (1990) Identification of two human ferritin H genes on the short arm of chromosome 6.

[^]
42.

Leggett BA et. al. (1990) Prevalence of haemochromatosis amongst asymptomatic Australians.

[^]
43.

Borecki IB et. al. (1990) Percent transferrin saturation in segregating hemochromatosis.

[^]
44.

Milman N et. al. (1990) Family studies of hereditary hemochromatosis in Denmark and the Faroe Islands.

[^]
45.

Borecki IB et. al. (1990) Combined segregation and linkage analysis of genetic hemochromatosis using affection status, serum iron, and HLA.

[^]
46.

David V et. al. (1989) Ferritin H gene polymorphism in idiopathic hemochromatosis.

[^]
47.

Summers KM et. al. (1989) HLA determinants in an Australian population of hemochromatosis patients and their families.

[^]
48.

Borecki IB et. al. (1989) Segregation of genetic hemochromatosis indexed by latent capacity of transferrin.

[^]
49.

Cragg SJ et. al. (1988) HLA class I and H ferritin gene polymorphisms in normal subjects and patients with haemochromatosis.

[^]
50.

David V et. al. (1986) DNA polymorphism related to the idiopathic hemochromatosis gene: evidence in a recombinant family.

[^]
51.

Meyer TE et. al. (1987) The HLA linked iron loading gene in an Afrikaner population.

[^]
52.

Lucotte G et. al. (1986) Association between a 10 kb Pvu II restriction fragment of genomic DNA with the hemochromatosis gene.

[^]
53.

Diamond T et. al. (1989) Osteoporosis in hemochromatosis: iron excess, gonadal deficiency, or other factors?

[^]
54.

McGill JR et. al. (1987) Human ferritin H and L sequences lie on ten different chromosomes.

[^]
55.

None (1988) Immune tolerance in nonhemophilic patients with antibodies to factor VIII.

[^]
56.

Karlsson M et. al. (1988) Prevalence of hemochromatosis in Finland.

[^]
57.

Milman N et. al. (1988) HLA determinants in 70 Danish patients with idiopathic haemochromatosis.

[^]
58.

Edwards CQ et. al. (1988) Prevalence of hemochromatosis among 11,065 presumably healthy blood donors.

[^]
59.

Edwards CQ et. al. (1986) Mapping the locus for hereditary hemochromatosis: localization between HLA-B and HLA-A.

[^]
60.

Simon M et. al. (1987) A study of 609 HLA haplotypes marking for the hemochromatosis gene: (1) mapping of the gene near the HLA-A locus and characters required to define a heterozygous population and (2) hypothesis concerning the underlying cause of hemochromatosis-HLA association.

[^]
61.

Powell LW et. al. (1987) Genetic hemochromatosis and HLA linkage.

[^]
62.

Eriksson S et. al. (1986) A Swedish family with alpha 1-antitrypsin deficiency, haemochromatosis, haemoglobinopathy D and early death in liver cirrhosis.

[^]
63.

Siemons LJ et. al. (1987) Hypogonadotropic hypogonadism in hemochromatosis: recovery of reproductive function after iron depletion.

[^]
64.

Escobar GJ et. al. (1987) Primary hemochromatosis in childhood.

[^]
65.

Niederau C et. al. (1985) Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis.

[^]
66.

MacSween RN et. al. (1973) Hepatic cirrhosis: a clinico-pathological review of 520 cases.

[^]
67.

Saddi R et. al. (1974) Idiopathic haemochromatosis: an autosomal recessive disease.

[^]
68.

Balcerzak SP et. al. (1966) Idiopathic hemochromatosis. A study of three families.

[^]
69.

Charlton RW et. al. (1967) Idiopathic hemochromatosis in young subjects. Clinical, pathological, and chemical findings in four patients.

[^]
70.

Felts JH et. al. (1967) Hemochromatosis in two young sisters. Case studies and a family survey.

[^]
71.

Cazzola M et. al. (1983) Juvenile idiopathic haemochromatosis: a life-threatening disorder presenting as hypogonadotropic hypogonadism.

[^]
72.

Ritter B et. al. (1984) HLA as a marker of the hemochromatosis gene in Sweden.

[^]
73.

Le Mignon L et. al. (1983) An HLA-All association with the hemochromatosis allele?

[^]
74.

Anand S et. al. () Idiopathic hemochromotosis and alpha-1-antitrypsin deficiency: coexistence in a family with progressive liver disease in the proband.

[^]
75.

Olsson KS et. al. (1984) Screening for iron overload using transferrin saturation.

[^]
76.

Muir WA et. al. (1984) Evidence for heterogeneity in hereditary hemochromatosis. Evaluation of 174 persons in nine families.

[^]
77.

Olsson KS et. al. (1983) Prevalence of iron overload in central Sweden.

[^]
78.

Dadone MM et. al. (1982) Hereditary hemochromatosis. Analysis of laboratory expression of the disease by genotype in 18 pedigrees.

[^]
79.

Bassett ML et. al. (1982) Idiopathic hemochromatosis: demonstration of homozygous-heterozygous mating by HLA typing of families.

[^]
80.

None (1982) A foundation for hemochromatosis.

[^]
81.

Edwards CQ et. al. (1981) Hereditary hemochromatosis: contributions of genetic analyses.

[^]
82.

Simon M et. al. (1980) Idiopathic hemochromatosis: a study of biochemical expression in 247 heterozygous members of 63 families: evidence for a single major HLA-linked gene.

[^]
83.

Beaumont C et. al. (1980) Hepatic and serum ferritin concentrations in patients with idiopathic hemochromatosis.

[^]
84.

Valberg LS et. al. (1980) Clinical and biochemical expression of the genetic abnormality in idiopathic hemochromatosis.

[^]
85.

Edwards CQ et. al. (1980) Homozygosity for hemochromatosis: clinical manifestations.

[^]
86.

Cutler DJ et. al. (1980) Hemochromatosis heart disease: an unemphasized cause of potentially reversible restrictive cardiomyopathy.

[^]
87.

Elzouki AN et. al. (1995) Increased PiZ gene frequency for alpha 1 antitrypsin in patients with genetic haemochromatosis.

[^]
88.

Hashimoto K et. al. (1995) A gene outside the human MHC related to classical HLA class I genes.

[^]
89.

Calandro LM et. al. (1995) Characterization of a recombinant that locates the hereditary hemochromatosis gene telomeric to HLA-F.

[^]
90.

Jazwinska EC et. al. (1995) Haplotype analysis in Australian hemochromatosis patients: evidence for a predominant ancestral haplotype exclusively associated with hemochromatosis.

[^]
91.

Barton JC et. al. (1994) Blood lead concentrations in hereditary hemochromatosis.

[^]
92.

None () A prevalence and fertility study of haemochromatosis in Saguenay-Lac-Saint-Jean.

[^]
93.

Goei VL et. al. (1994) Isolation of novel non-HLA gene fragments from the hemochromatosis region (6p21.3) by cDNA hybridization selection.

[^]
94.

Yaouanq J et. al. (1994) Anonymous marker loci within 400 kb of HLA-A generate haplotypes in linkage disequilibrium with the hemochromatosis gene (HFE)

[^]
95.

Jazwinska EC et. al. (1993) Localization of the hemochromatosis gene close to D6S105.

[^]
96.

Deugnier YM et. al. (1993) Primary liver cancer in genetic hemochromatosis: a clinical, pathological, and pathogenetic study of 54 cases.

[^]
97.

el Kahloun A et. al. (1993) Localization of seven new genes around the HLA-A locus.

[^]
98.

Raha-Chowdhury R et. al. (1996) A new highly polymorphic marker in the 5' untranslated region of HLA-F shows strong allelic association with haemochromatosis.

[^]
99.

Rothenberg BE et. al. (1996) beta2 knockout mice develop parenchymal iron overload: A putative role for class I genes of the major histocompatibility complex in iron metabolism.

[^]
100.

None (1996) Haemochromatosis: strike while the iron is hot.

[^]
101.

Feder JN et. al. (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.

[^]
102.

Totaro A et. al. (1996) Hereditary hemochromatosis: generation of a transcription map within a refined and extended map of the HLA class I region.

[^]
103.

Jazwinska EC et. al. (1996) Haemochromatosis and HLA-H.

[^]
104.

Jouanolle AM et. al. (1996) Haemochromatosis and HLA-H.

[^]
105.

Beutler E et. al. (1996) Mutation analysis in hereditary hemochromatosis.

[^]
106.

Bulaj ZJ et. al. (1996) Clinical and biochemical abnormalities in people heterozygous for hemochromatosis.

[^]
107.

Hashimoto K et. al. (1997) Identification of a mouse homolog for the human hereditary haemochromatosis candidate gene.

[^]
108.

Roberts AG et. al. (1997) Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda.

[^]
109.

Robson KJ et. al. (1997) Haemochromatosis: a gene at last?

[^]
110.

Mercier B et. al. (1997) Putting a hold on 'HLA-H'.

[^]
111.

Bodmer JG et. al. (1997) Putting a hold on "HLA-H'. The WHO Nomenclature Committee for Factors of the HLA System.

[^]
112.

Carella M et. al. (1997) Mutation analysis of the HLA-H gene in Italian hemochromatosis patients.

[^]
113.

Parkkila S et. al. (1997) Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tract.

[^]
114.

Merryweather-Clarke AT et. al. (1997) Global prevalence of putative haemochromatosis mutations.

[^]
115.

Feder JN et. al. (1997) The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression.

[^]
116.

Roth M et. al. (1997) Absence of the hemochromatosis gene Cys282Tyr mutation in three ethnic groups from Algeria (Mzab), Ethiopia, and Senegal.

[^]
117.

Beutler E et. al. (1997) HLA-H mutations in the Ashkenazi Jewish population.

[^]
118.

Beutler E et. al. (1997) HLA-H and associated proteins in patients with hemochromatosis.

[^]
119.

Rhodes DA et. al. (1997) Homozygosity for the predominant Cys282Tyr mutation and absence of disease expression in hereditary haemochromatosis.

[^]
120.

None (1997) The significance of the 187G (H63D) mutation in hemochromatosis.

[^]
121.

Jouanolle AM et. al. (1997) A candidate gene for hemochromatosis: frequency of the C282Y and H63D mutations.

[^]
122.

Waheed A et. al. (1997) Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells.

[^]
123.

Beckman LE et. al. () Ethnic differences in the HFE codon 282 (Cys/Tyr) polymorphism.

[^]
124.

Parkkila S et. al. (1997) Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis.

[^]
125.

None (1997) Haemochromatosis, HFE and genetic complexity.

[^]
126.

Mura C et. al. (1997) Phenotype-genotype correlation in haemochromatosis subjects.

[^]
127.

None (1997) A simple genetic test identifies 90% of UK patients with haemochromatosis. The UK Haemochromatosis Consortium.

[^]
128.

Feder JN et. al. (1998) The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding.

[^]
129.

None (1998) Targeted disruption of the HFE gene.

[^]
130.

Zhou XY et. al. (1998) HFE gene knockout produces mouse model of hereditary hemochromatosis.

[^]
131.

Lebrón JA et. al. (1998) Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor.

[^]
132.

Lalouel JM et. al. (1985) Genetic analysis of idiopathic hemochromatosis using both qualitative (disease status) and quantitative (serum iron) information.

[^]
133.

Piperno A et. al. (1998) Heterogeneity of hemochromatosis in Italy.

[^]
134.

Cullen LM et. al. (1998) The hemochromatosis 845 G-->A and 187 C-->G mutations: prevalence in non-Caucasian populations.

[^]
135.

Pérez Roldán F et. al. (1998) Hemochromatosis presenting as acute liver failure after iron supplementation.

[^]
136.

Lonjou C et. al. (1998) Allelic association under map error and recombinational heterogeneity: a tale of two sites.

[^]
137.

Burt MJ et. al. (1998) The significance of haemochromatosis gene mutations in the general population: implications for screening.

[^]
138.

None (1998) Celtic origin of the C282Y mutation of hemochromatosis.

[^]
139.

Powell LW et. al. (1998) Diagnosis of hemochromatosis.

[^]
140.

Barton JC et. al. (1998) Management of hemochromatosis. Hemochromatosis Management Working Group.

[^]
141.

Looker AC et. al. (1998) Prevalence of elevated serum transferrin saturation in adults in the United States.

[^]
142.

Phatak PD et. al. (1998) Prevalence of hereditary hemochromatosis in 16031 primary care patients.

[^]
143.

Brittenham GM et. al. (1998) Research priorities in hereditary hemochromatosis.

[^]
144.

Waheed A et. al. (1999) Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum.

[^]
145.

Fleming RE et. al. (1999) Mechanism of increased iron absorption in murine model of hereditary hemochromatosis: increased duodenal expression of the iron transporter DMT1.

[^]
146.

Roy CN et. al. (1999) The hereditary hemochromatosis protein, HFE, specifically regulates transferrin-mediated iron uptake in HeLa cells.

[^]
147.

Rochette J et. al. (1999) Multicentric origin of hemochromatosis gene (HFE) mutations.

[^]
148.

Merryweather-Clarke AT et. al. (1999) A retrospective anonymous pilot study in screening newborns for HFE mutations in Scandinavian populations.

[^]
149.

Grove J et. al. (1998) Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease.

[^]
150.

Mura C et. al. (1999) HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis.

[^]
151.

Levy JE et. al. (1999) The C282Y mutation causing hereditary hemochromatosis does not produce a null allele.

[^]
152.

Zoller H et. al. (1999) Duodenal metal-transporter (DMT-1, NRAMP-2) expression in patients with hereditary haemochromatosis.

[^]
153.

de Villiers JN et. al. (1999) Spectrum of mutations in the HFE gene implicated in haemochromatosis and porphyria.

[^]
154.

Jeffrey GP et. al. (1999) Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis.

[^]
155.

Olynyk JK et. al. (1999) A population-based study of the clinical expression of the hemochromatosis gene.

[^]
156.

Gomez PS et. al. (1999) Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results.

[^]
157.

Bahram S et. al. (1999) Experimental hemochromatosis due to MHC class I HFE deficiency: immune status and iron metabolism.

[^]
158.

Noll WW et. al. (1999) Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results.

[^]
159.

Willis G et. al. (2000) Incidence of liver disease in people with HFE mutations.

[^]
160.

Hickman PE et. al. (2000) Automated measurement of unsaturated iron binding capacity is an effective screening strategy for C282Y homozygous haemochromatosis.

[^]
161.

Griffiths W et. al. (2000) Haemochromatosis: novel gene discovery and the molecular pathophysiology of iron metabolism.

[^]
162.

Hussain SP et. al. (2000) Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: oxyradical overload diseases.

[^]
163.

Bulaj ZJ et. al. (2000) Disease-related conditions in relatives of patients with hemochromatosis.

[^]
164.

Fleming RE et. al. (2001) Mouse strain differences determine severity of iron accumulation in Hfe knockout model of hereditary hemochromatosis.

[^]
165.

Brown AS et. al. () Hemochromatosis-associated morbidity in the United States: an analysis of the National Hospital Discharge Survey, 1979-1997.

[^]
166.

Sproule TJ et. al. (2001) Naturally variant autosomal and sex-linked loci determine the severity of iron overload in beta 2-microglobulin-deficient mice.

[^]
167.

Steinberg KK et. al. (2001) Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States.

[^]
168.

Barton JC et. al. () Diagnosis of hemochromatosis in family members of probands: a comparison of phenotyping and HFE genotyping.

[^]
169.

Aguilar-Martinez P et. al. (2001) Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause?

[^]
170.

Moczulski DK et. al. (2001) Role of hemochromatosis C282Y and H63D mutations in HFE gene in development of type 2 diabetes and diabetic nephropathy.

[^]
171.

Pozzato G et. al. (2001) Haemochromatosis gene mutations in a clustered Italian population: evidence of high prevalence in people of Celtic ancestry.

[^]
172.

Cairo G et. al. (2001) Reduced serum ceruloplasmin levels in hereditary haemochromatosis.

[^]
173.

Barton JC et. al. () Inheritance of two HFE mutations in African Americans: cases with hemochromatosis phenotypes and estimates of hemochromatosis phenotype frequency.

[^]
174.

Thénié AC et. al. (2001) Identification of an endogenous RNA transcribed from the antisense strand of the HFE gene.

[^]
175.

Mura C et. al. (2001) Variation of iron loading expression in C282Y homozygous haemochromatosis probands and sib pairs.

[^]
176.

Roy CN et. al. (2001) Recent advances in disorders of iron metabolism: mutations, mechanisms and modifiers.

[^]
177.

Beutler E et. al. (2002) Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.

[^]
178.

de Juan D et. al. (2001) HFE gene mutations analysis in Basque hereditary haemochromatosis patients and controls.

[^]
179.

Townsend A et. al. (2002) Role of HFE in iron metabolism, hereditary haemochromatosis, anaemia of chronic disease, and secondary iron overload.

[^]
180.

Cardoso CS et. al. (2002) Co-selection of the H63D mutation and the HLA-A29 allele: a new paradigm of linkage disequilibrium?

[^]
181.

Trinder D et. al. (2002) Iron uptake from plasma transferrin by the duodenum is impaired in the Hfe knockout mouse.

[^]
182.

Hofmann WK et. al. (2002) Mutation analysis of transferrin-receptor 2 in patients with atypical hemochromatosis.

[^]
183.

Poullis A et. al. (2002) Clinical haemochromatosis in HFE mutation carriers.

[^]
184.

Drakesmith H et. al. (2002) The hemochromatosis protein HFE inhibits iron export from macrophages.

[^]
185.

McCune CA et. al. (2002) Hereditary haemochromatosis: only 1% of adult HFEC282Y homozygotes in South Wales have a clinical diagnosis of iron overload.

[^]
186.

Nicolas G et. al. (2003) Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis.

[^]
187.

Muckenthaler M et. al. (2003) Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis.

[^]
188.

Le Gac G et. al. () Phenotypic expression of the C282Y/Q283P compound heterozygosity in HFE and molecular modeling of the Q283P mutation effect.

[^]
189.

Halsall DJ et. al. (2003) Typical type 2 diabetes mellitus and HFE gene mutations: a population-based case - control study.

[^]
190.

Milman N et. al. (2003) Evidence that the Cys282Tyr mutation of the HFE gene originated from a population in Southern Scandinavia and spread with the Vikings.

[^]
191.

Merryweather-Clarke AT et. al. (2003) Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis.

[^]
192.

Zoller H et. al. (2003) Duodenal cytochrome b and hephaestin expression in patients with iron deficiency and hemochromatosis.

[^]
193.

NUSSBAUMER T et. al. (1952) [Juvenile hemochromatosis in three sisters and one brother associated with consanguinity of the parents; anatomo-clinical and genetic study of the endocrino-hepato-myocardial syndrome].

[^]
194.

DEBRE R et. al. (1958) Genetics of haemochromatosis.

[^]
195.

BOTHWELL TH et. al. (1959) A familial study in idiopathic hemochromatosis.

[^]
196.

PERKINS KW et. al. (1965) IDIOPATHIC HAEMOCHROMATOSIS IN CHILDREN; REPORT OF A FAMILY.

[^]
197.

JOHNSON GB et. al. (1962) Familial aspects of idiopathic hemochromatosis.

[^]
198.

Peterlin B et. al. (2003) A hemochromatosis-causing mutation C282Y is a risk factor for proliferative diabetic retinopathy in Caucasians with type 2 diabetes.

[^]
199.

Tomatsu S et. al. (2003) Contribution of the H63D mutation in HFE to murine hereditary hemochromatosis.

[^]
200.

Livesey KJ et. al. (2004) The 16189 variant of mitochondrial DNA occurs more frequently in C282Y homozygotes with haemochromatosis than those without iron loading.

[^]
201.

Robson KJ et. al. (2004) Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease.

[^]
202.

Andersen RV et. al. (2004) Hemochromatosis mutations in the general population: iron overload progression rate.

[^]
203.

Roy CN et. al. (2004) An Hfe-dependent pathway mediates hyposideremia in response to lipopolysaccharide-induced inflammation in mice.

[^]
204.

None (2004) Hereditary hemochromatosis--a new look at an old disease.

[^]
205.

Le Gac G et. al. (2004) The recently identified type 2A juvenile haemochromatosis gene (HJV), a second candidate modifier of the C282Y homozygous phenotype.

[^]
206.

Mehrany K et. al. (2004) Association of porphyria cutanea tarda with hereditary hemochromatosis.

[^]
207.

Distante S et. al. (2004) The origin and spread of the HFE-C282Y haemochromatosis mutation.

[^]
208.

Oliva R et. al. (2004) The HFE gene is associated to an earlier age of onset and to the presence of diabetic nephropathy in diabetes mellitus type 2.

[^]
209.

Lee PL et. al. (2004) Hemojuvelin (HJV) mutations in persons of European, African-American and Asian ancestry with adult onset haemochromatosis.

[^]
210.

Valenti L et. al. (2004) The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis.

[^]
211.

McDermott JH et. al. (2005) Hypogonadism in hereditary hemochromatosis.

[^]
212.

Ka C et. al. (2005) The Q283P amino-acid change in HFE leads to structural and functional consequences similar to those described for the mutated 282Y HFE protein.

[^]
213.

Drakesmith H et. al. (2005) HIV-1 Nef down-regulates the hemochromatosis protein HFE, manipulating cellular iron homeostasis.

[^]
214.

Rohrlich PS et. al. (2005) Direct recognition by alphabeta cytolytic T cells of Hfe, a MHC class Ib molecule without antigen-presenting function.

[^]
215.

Matas M et. al. (2006) Prevalence of HFE C282Y and H63D in Jewish populations and clinical implications of H63D homozygosity.

[^]
216.

Barton JC et. al. (2006) Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in Native Americans and whites in the Hemochromatosis and Iron Overload Screening Study.

[^]
217.

Sarić M et. al. (2006) Frequency of the hemochromatosis gene mutations in the population of Serbia and Montenegro.

[^]
218.

Ludwiczek S et. al. (2007) Ca2+ channel blockers reverse iron overload by a new mechanism via divalent metal transporter-1.

[^]
219.

Adams PC et. al. (2007) Haemochromatosis.

[^]
220.

Allen KJ et. al. (2008) Iron-overload-related disease in HFE hereditary hemochromatosis.

[^]
221.

Waalen J et. al. (2008) Iron-overload-related disease in HFE hereditary hemochromatosis.

[^]
222.

None (2008) Iron-overload-related disease in HFE hereditary hemochromatosis.

[^]
223.

Davis TM et. al. (2008) Prevalence, characteristics, and prognostic significance of HFE gene mutations in type 2 diabetes: the Fremantle Diabetes Study.

[^]
224.

Le Gac G et. al. (2008) Homozygous deletion of HFE produces a phenotype similar to the HFE p.C282Y/p.C282Y genotype.

[^]
225.

Benyamin B et. al. (2009) Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels.

[^]
226.

Nairz M et. al. (2009) Absence of functional Hfe protects mice from invasive Salmonella enterica serovar Typhimurium infection via induction of lipocalin-2.

[^]
227.

Cippà PE et. al. (2013) Increased height in HFE hemochromatosis.

[^]
228.

Hill WG et. al. (1968) Linkage disequilibrium in finite populations.

[^]